...
首页> 外文期刊>Breast cancer research and treatment. >Predictive factors of response to intensive decongestive physiotherapy in upper limb lymphedema after breast cancer treatment: a cohort study.
【24h】

Predictive factors of response to intensive decongestive physiotherapy in upper limb lymphedema after breast cancer treatment: a cohort study.

机译:乳腺癌治疗后上肢淋巴水肿对强化减充血理疗反应的预测因素:一项队列研究。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Lymphedema is a frequent complication after breast cancer treatment. Reduction of lymphedema volume is obtained during an intensive phase with daily physiotherapy. Response to treatment remains unknown prior treatment. We purposed to analyze predictors of response of lymphedema treatment throughout the first course of physiotherapy. DESIGN: Patients with secondary arm lymphedema were recruited in a single lymphology unit between 2001 and 2004. For each patient, the following data were recorded: characteristics of breast cancer treatment, patient characteristics, body mass index and lymphedema volume prior and at the end of treatment. RESULTS: Three hundred and fifty-seven women (mean age: 53+/-11 years) were included. Initial excess volume of lymphedema was correlated to body mass index and duration of lymphedema. Mean duration of intensive decongestive therapy was 11.8+/-3.3 days. Mean excess volume of lymphedema was 1067+/-622 ml prior treatment and 663+/-366 ml after treatment (p<0.001),percentage of excess volume of lymphedema was 59+/-34% and 36+/-19%, respectively. Absolute volume reduction was 404+/-33 ml (p<0.001). Body mass index and duration of lymphedema before treatment were the two predictors of absolute reduction of lymphedema volume. Higher was the body mass index or the duration of lymphedema, more important was the absolute reduction of lymphedema volume. Mean relative percentage of volume reduction was 36+/-14% whatever mass index or the duration of lymphedema was. CONCLUSION: Duration of lymphedema from cancer treatment and body mass index were the only two predictors of absolute reduction of lymphedema volume after intensive decongestive physiotherapy. For all patients this latter treatment is highly effective in management of secondary upper limb lymphedema after breast cancer.
机译:背景:淋巴水肿是乳腺癌治疗后的常见并发症。在日常理疗的强化阶段,可减少淋巴水肿的体积。对治疗的反应在之前的治疗中仍然未知。我们的目的是在整个物理治疗的第一过程中分析淋巴水肿治疗反应的预测因子。设计:在2001年至2004年之间,在单个淋巴学部门招募了继发性臂淋巴水肿的患者。每位患者记录以下数据:乳腺癌治疗特征,患者特征,体重指数和淋巴水肿量。治疗。结果:包括357名妇女(平均年龄:53 +/- 11岁)。最初过多的淋巴水肿与体重指数和淋巴水肿持续时间相关。强化减充血治疗的平均持续时间为11.8 +/- 3.3天。治疗前平均淋巴水肿过量为1067 +/- 622 ml,治疗后为663 +/- 366 ml(p <0.001),淋巴水肿的过量百分比为59 +/- 34%和36 +/- 19%,分别。绝对体积减少为404 +/- 33ml(p <0.001)。体重指数和治疗前淋巴水肿持续时间是绝对减少淋巴水肿量的两个预测指标。体重指数或淋巴水肿持续时间越高,淋巴水肿量的绝对减少越重要。无论质量指数或淋巴水肿持续时间如何,体积减少的平均相对百分比为36 +/- 14%。结论:从癌症治疗到淋巴水肿的持续时间以及体重指数是强化去充血理疗后淋巴水肿量绝对减少的两个预测指标。对于所有患者,后一种治疗在乳腺癌术后继发上肢淋巴水肿的治疗中非常有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号